// App-Quantinova.ai

: Utility of Leucovorin Rescue in Patients with Acute Lymphoblastic Leukemia (ALL) Treated with the Mini-Hypercvd Regimen

Researchers

Presenter

  • Caitlin R. Rausch

Principal Investigators

  • Shilpa Paul

  • Hagop M. Kantarjian

  • Farhad Ravandi

  • Nicholas J Short

  • Koji Sasaki

  • Maria Khouri

  • Jovitta Jacob

  • Kathryn S Montalbano

  • Philip A. Thompson

  • Nitin Jain

  • Musa Yilmaz

  • Kiran Naqvi

  • Maro N. Ohanian

  • Patrice Nasnas

  • Zeev E. Estrov

  • Susan M. O'Brien

  • Elias J. Jabbour

Medical Centers

  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • leucovorin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01371630

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved